Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Oudiz · SciRah

Researcher profile · Semantic Scholar

R. Oudiz

Share profile

R. Oudiz — researcher profile on SciRah

h-index: 52
Works: 205
Citations: 17K

Most-cited papers

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
N. Galie', J. Barberà, A. Frost, H. Ghofrani +15 more
2015New England Journal of Medicine1,042 citations Open access
Semantic Scholar
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
A. Vonk-Noordegraaf, F. Haddad, K. Chin, P. Forfia +9 more
2013Journal of the American College of Cardiology947 citations Open access
Semantic Scholar
Pulmonary Vascular Hemodynamic Response to Exercise in Cardiopulmonary Diseases
G. Lewis, E. Bossone, R. Naeije, E. Grünig +7 more
2013Circulation360 citations Open access
Semantic Scholar
Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study
D. Bonderman, S. Ghio, S. Felix, H. Ghofrani +7 more
2013Circulation316 citations Open access
Semantic Scholar
Diagnosis of pulmonary hypertension
A. Frost, D. Badesch, J. Gibbs, D. Gopalan +6 more
2019European Respiratory Journal287 citations Open access
Semantic Scholar
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
C. Rhodes, Ken Batai, M. Bleda, M. Haimel +114 more
2018The Lancet Respiratory Medicine156 citations Open access
Semantic Scholar
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap.
V. McLaughlin, A. Langer, M. Tan, P. Clements +4 more
2013Chest139 citations
Semantic Scholar
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial
R. White, C. Jerjes-Sánchez, G. Meyer, T. Pulido +169 more
2019American Journal of Respiratory and Critical Care Medicine123 citations Open access
Semantic Scholar
ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension.
D. Badesch, J. Feldman, A. Keogh, M. Mathier +9 more
2012Cardiovascular Therapeutics111 citations
Semantic Scholar
Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension.
J. Fritz, C. Blair, R. Oudiz, C. Dufton +4 more
2013Chest108 citations Open access
Semantic Scholar
Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.
R. Barst, R. Oudiz, A. Beardsworth, B. Brundage +4 more
2011The Journal of Heart and Lung Transplantation108 citations
Semantic Scholar
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.
V. McLaughlin, J. Vachiéry, R. Oudiz, S. Rosenkranz +10 more
2019The Journal of Heart and Lung Transplantation107 citations Open access
Semantic Scholar
Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
M. Gomberg-Maitland, C. Dufton, R. Oudiz, R. Benza
2011Journal of the American College of Cardiology74 citations Open access
Semantic Scholar
Usefulness of Right-to-Left Shunting and Poor Exercise Gas Exchange for Predicting Prognosis in Patients with Pulmonary Arterial Hypertension
R. Oudiz, Raghu Midde, Arsen Hovenesyan, Xing-Guo Sun +3 more
2010American Journal of Cardiology73 citations Open access
Semantic Scholar
The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH
P. Clements, M. Tan, V. McLaughlin, R. Oudiz +4 more
2011Annals of the Rheumatic Diseases72 citations
Semantic Scholar
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.
M. Hoeper, V. McLaughlin, J. Barberà, A. Frost +12 more
2016The Lancet Respiratory Medicine69 citations
Semantic Scholar
Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?
E. Horn, M. Chakinala, R. Oudiz, E. Joseloff +1 more
2020Pulmonary Circulation60 citations Open access
Semantic Scholar
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
J. Ryan, L. Melendres‐Groves, R. Zamanian, R. Oudiz +3 more
2020Pulmonary Circulation57 citations Open access
Semantic Scholar
Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study.
R. Oudiz, B. Brundage, N. Galie', H. Ghofrani +5 more
2012Journal of the American College of Cardiology55 citations Open access
Semantic Scholar
Right Heart Adaptation to Pulmonary ArterialHypertension
A. Vonk-Noordegraaf, F. Haddad, K. Chin, S. Kawut +7 more
201348 citations
Semantic Scholar
Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension.
J. Klinger, R. Oudiz, R. Spence, D. Despain +1 more
2011American Journal of Cardiology47 citations
Semantic Scholar
Update of Screening and Diagnostic Modalities for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
A. Young, V. Nagaraja, Mark Basilious, Mirette G. Habib +12 more
2018Seminars in Arthritis & Rheumatism41 citations Open access
Semantic Scholar
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
C. Vizza, I. Lang, R. Badagliacca, R. Benza +31 more
2021American Journal of Respiratory and Critical Care Medicine40 citations Open access
Semantic Scholar
Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design
S. Ghio, D. Bonderman, S. Felix, H. Ghofrani +6 more
2012European Journal of Heart Failure35 citations Open access
Semantic Scholar
Classification of Pulmonary Hypertension.
R. Oudiz
2016Cardiology Clinics33 citations
Semantic Scholar
Phase I Safety Study of Ranolazine in Pulmonary Arterial Hypertension
M. Gomberg-Maitland, R. Schilz, Anuj Mediratta, K. Addetia +4 more
2015Pulmonary Circulation31 citations Open access
Semantic Scholar
[Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology].
A. Vonk-Noordegraaf, F. Haddad, K. Chin, P. Forfia +9 more
2014Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır30 citations
Semantic Scholar
Updating clinical endpoint definitions
P. Hassoun, S. Nikkho, E. Rosenzweig, Gail Moreschi +8 more
2013Pulmonary Circulation22 citations Open access
Semantic Scholar
Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1).
S. Shapiro, F. Torres, J. Feldman, A. Keogh +5 more
2017Respiratory Medicine21 citations Open access
Semantic Scholar
Quality indicator set for systemic sclerosis
D. Khanna, O. Kowal-Bielecka, P. Khanna, A. Lapinska +12 more
2011Clinical and Experimental Rheumatology21 citations
Semantic Scholar
Initial Data Report from LARIAT: A Phase 2 Study of Bardoxolone Methyl in PAH Patients on Stable Background Therapy
R. Oudiz, C. Meyer, M. Chin, J. Feldman +8 more
201520 citations
Semantic Scholar
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
R. White, A. Vonk-Noordegraaf, S. Rosenkranz, R. Oudiz +9 more
2019Respiratory Research18 citations Open access
Semantic Scholar
Conversion From Sildenafil to Tadalafil
R. Frantz, L. Durst, C. Burger, R. Oudiz +5 more
2014Journal of Cardiovascular Pharmacology and Therapeutics14 citations Open access
Semantic Scholar
Death in pulmonary arterial hypertension.
R. Oudiz
2013American Journal of Respiratory and Critical Care Medicine14 citations
Semantic Scholar
Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension: 3-Year Outcome
R. Oudiz, M. Allard, C. Blair, H. Gillies
201114 citations
Semantic Scholar
ATHENA-1: Hemodynamic Improvements Following the Addition of Ambrisentan to Background PDE5i Therapy in Patients With Pulmonary Arterial Hypertension
R. Oudiz, S. Shapiro, F. Torres, J. Feldman +4 more
201113 citations
Semantic Scholar
Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
J. Kingrey, C. Miller, V. Franco, Jimmy S. Smith +12 more
2023Pulmonary Circulation10 citations Open access
Semantic Scholar
Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil.
C. Miller, V. Franco, Jimmy S. Smith, Vijay P. Balasubramanian +12 more
2023Respiratory Medicine9 citations Open access
Semantic Scholar
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository
H. Farber, Murali M. Chakinala, Michelle Cho, R. Frantz +7 more
2023Pulmonary Circulation9 citations Open access
Semantic Scholar
The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension
P. Forfia, R. Benza, M. D’Alto, T. De Marco +15 more
2023Pulmonary Circulation8 citations Open access
Semantic Scholar
An Expert Panel Delphi Consensus Statement on Patient Selection and Management for Transitioning Between Oral and Inhaled Treprostinil.
Franck F. Rahaghi, R. Allen, Vijay P. Balasubramanian, M. Chakinala +7 more
2020Pulmonary Pharmacology & Therapeutics7 citations
Semantic Scholar
ABI-009, nab-Sirolimus, an mTOR Inhibitor with High Lung Accumulation in Preclinical Models Is Active in Patients with Severe Pulmonary Arterial Hypertension
M. Simon, M. Gomberg-Maitland, R. Oudiz, R. Machado +7 more
2019C26. LET IT BLEED: ENDOTHELIAL INJURY AND ANGIOGENESIS IN PULMONARY HYPERTENSION7 citations
Semantic Scholar
Severe Pulmonary Arterial Hypertension Treated with ABI-009, nab-Sirolimus, an mTOR Inhibitor
M. Simon, M. Gomberg-Maitland, R. Oudiz, R. Machado +7 more
2019The Journal of Heart and Lung Transplantation6 citations
Semantic Scholar
Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Patients with Sickle Cell Disease
M. Agarwal, M. Shah, Brijesh Patel, V. Nolan +4 more
2018American Journal of Respiratory and Critical Care Medicine6 citations Open access
Semantic Scholar
Conversion From Sildenafil To Tadalafil: Initial Results From The Sildenafil To Tadalafil In Pulmonary Arterial Hypertension (SITAR) Study
R. Frantz, C. Burger, R. Oudiz, S. Walker
2011Asian Test Symposium6 citations
Semantic Scholar
Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?’”
E. Horn, M. Chakinala, R. Oudiz, E. Joseloff +1 more
2020Pulmonary Circulation5 citations Open access
Semantic Scholar
57 ATHENA-1: Long Term Clinical Improvements Following the Addition of Ambrisentan to Background PDE5i Therapy in Patients with Pulmonary Arterial Hypertension
S. Shapiro, H. Gillies, M. Allard, C. Blair +1 more
20125 citations
Semantic Scholar
Long-Term Follow-Up In PAH Patients Dosed With Beraprost Sodium Modified Release (BPS-MR) Tablets, An Oral Twice Daily Prostacyclin Analogue
R. Oudiz, R. Benza, M. Delcroix, S. Gaine +4 more
2011Asian Test Symposium5 citations
Semantic Scholar
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
N. Zhu, E. Świetlik, C. Welch, M. Pauciulo +99 more
2021Genome Medicine4 citations Open access
Semantic Scholar
An Advanced Protocol-Driven Transition from Parenteral Prostanoids to Inhaled Trepostinil in Pulmonary Arterial Hypertension
R. Oudiz, M. Agarwal, F. Rischard, T. De Marco
2016Pulmonary Circulation4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Frost×9
Invite
A. Frost — researcher profile on SciRah
C. Blair×9
Invite
C. Blair — researcher profile on SciRah
V. McLaughlin×8
Invite
V. McLaughlin — researcher profile on SciRah
F. Torres×8
Invite
F. Torres — researcher profile on SciRah

×7

Invite

H. Gillies — researcher profile on SciRah

M. Chakinala×7

Invite

M. Chakinala — researcher profile on SciRah

Invite

J. Elwing — researcher profile on SciRah

E. Rosenzweig×7

Invite

E. Rosenzweig — researcher profile on SciRah

Invite

L. Rubin — researcher profile on SciRah

Invite

R. Naeije — researcher profile on SciRah

Invite

A. Torbicki — researcher profile on SciRah

Invite

S. Ghio — researcher profile on SciRah